ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 1 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $0 | -100.0% | 20 | -99.9% | 0.00% | – |
| Q3 2018 | $24,000 | -33.3% | 18,511 | -29.6% | 0.00% | – |
| Q2 2018 | $36,000 | -56.6% | 26,301 | -53.8% | 0.00% | – |
| Q1 2018 | $83,000 | +31.7% | 56,936 | +103.0% | 0.00% | – |
| Q4 2017 | $63,000 | -58.6% | 28,052 | -37.5% | 0.00% | – |
| Q3 2017 | $152,000 | -22.1% | 44,896 | -18.6% | 0.00% | – |
| Q2 2017 | $195,000 | +33.6% | 55,136 | +28.1% | 0.00% | – |
| Q1 2017 | $146,000 | +14.1% | 43,032 | +53.8% | 0.00% | – |
| Q4 2016 | $128,000 | +287.9% | 27,972 | +251.2% | 0.00% | – |
| Q3 2016 | $33,000 | – | 7,964 | +5671.0% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 138 | -84.5% | 0.00% | – |
| Q1 2016 | $4,000 | +300.0% | 892 | +286.1% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 231 | +0.9% | 0.00% | – |
| Q3 2015 | $1,000 | -66.7% | 229 | -67.0% | 0.00% | – |
| Q2 2015 | $3,000 | -25.0% | 693 | +14.4% | 0.00% | – |
| Q1 2015 | $4,000 | +300.0% | 606 | +96.1% | 0.00% | – |
| Q4 2014 | $1,000 | – | 309 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |